Skip to main content
  • Meeting abstract
  • Open access
  • Published:

P01-015 – Effect of Cochicine on cholesterol in FMF and BS


We and others have previously shown that patients with Familial Mediterranean Fever (FMF) had low cholesterol levels when compared to healthy controls [1, 2]. This was initially brought up by Ozkan E [3]. The causes of this abnormality are not understood. It could be due to an inherent effect of FMF or due to a lipid lowering effect of colchicine, as the patients in these studies were all regular users. Additionally, earlier studies had suggested that colchicine may have hypocholesterolemic effect.


We conducted a 12 week study to determine whether colchicine would decrease serum lipid levels in patients with FMF and Behçet's syndrome (BS). Lipid levels were measured in each patient before and after colchicine use.


Blood cholesterol and triglycerides levels were measured in 24 patients with FMF (11 M, 13 F) and 16 (8 M, 8 F) patients with BS who were registered at the outpatient clinic of Cerrahpasa Medical Faculty. All patients were naive to colchicine or immunosuppressive treatment or any other lipid lowering drugs at study entry. Blood cholesterol and triglycerides levels were measured again after 12 weeks of colchicine 1.5 mg daily. Colchicine was withdrawn in one patient with FMF because of liver toxicity and in another because of nausea. Two patients with FMF did not use colchicine and another with FMF was lost to follow-up. Colchicine was switched to azathioprine in 1 patient with BS because of active disease. Only patients who completed 12 weeks period were analyzed.


There were 19 (8 M, 11 F) patients with FMF and 15 (7 M, 8 F) patients with BS who completed the 12 week period. Patients with FMF were (mean age: 33.8±14.1 years) significantly younger than BS patients (mean age: 36.5±9.5) (P = 0.001). Colchicine did not change cholesterol and triglycerides levels in patients with FMF (T.Cholesterol: 169±77 vs 181±48 mg/dl, P = 0.58, Triglycerides: 122±82 vs128±70 mg/dl, P= 0.75, LDL:120±44 vs 112±40, P=0.35, HDL: 42±13 vs 47±11 mg/dl, P=0.1, before and after colchicine use, respectively). This was also true for BS patients (T.cholesterol:181±51 vs 172±44 mg/dl, P=0.53, triglycerides:112±63 vs 107±52 mg/dl, P=0.18, LDL:115±38 vs 106±40 mg/dl, P = 0.85, HDL:48±9 vs 48.3±9.9 mg/dl, P= 0.3).


This study provided no evidence that colchicine use affects lipid levels in patients with FMF and BS.

Disclosure of interest

None declared.


  1. Ugurlu S, Seyahi E, Cetinkaya F, Ozbakir F, Balci H, Ozdogan H: Intima-media thickening in patients with familial Mediterranean fever. Rheumatology (Oxford). 2009, 48 (8): 911-5.

    Article  Google Scholar 

  2. Akdogan A, Calguneri M, Yavuz B: Are familial Mediterranean fever (FMF) patients at increased risk for atherosclerosis? Impaired endothelial function and increased intima media thickness are found in FMF. J Am Coll Cardiol. 2006, 48: 2351-3.

    Article  PubMed  Google Scholar 

  3. Ozkan E, Okur O, Ekmekci A, Ozcan R, Tag T: A new approach to the treatment of periodic fever. Med Bull Istanbul. 1972, 5: 44-9.

    Google Scholar 

Download references

Author information

Authors and Affiliations


Rights and permissions

Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver ( ) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Cite this article

Ugurlu, S., Seyahi, E., Hanci, I. et al. P01-015 – Effect of Cochicine on cholesterol in FMF and BS. Pediatr Rheumatol 11 (Suppl 1), A19 (2013).

Download citation

  • Published:

  • DOI: